Multiomic analyses have shed light upon the molecular heterogeneity and complexity of triple-negative breast cancers (TNBCs). With increasing recognition that TNBC is not a single disease entity but encompasses different disease subtypes. a one-size-fits-all treatment paradigm has become obsolete. In this context. https://www.marcelovicente.com/product-category/vitamino-color-treatment/